









Markets
/
Stocks
/
nasdaq-slp
/

Simulations Plus Inc

SLP

14.570USD

+0.430+3.04%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

293.54MMarket Cap

LossP/E TTM



Simulations Plus Inc

14.570

+0.430+3.04%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Simulations Plus Inc

Currency: USD Updated: 2026-02-06

Key Insights

Simulations Plus Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 70 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 24.75.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Simulations Plus Inc's Score

Industry at a Glance

Industry Ranking

70 / 205

Overall Ranking

185 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Simulations Plus Inc Highlights

StrengthsRisks

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 32.90% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 79.18M.

Turnaround to Loss

The company's performance has turned to a loss, with the latest annual loss of USD .

Undervalued

The company’s latest PE is -4.56, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 15.79M shares, decreasing 20.73% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 1.66K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 0.61.

Analyst Rating

Based on 7 analysts

Buy

Current Rating

24.750

Target Price

+75.04%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Simulations Plus Inc is 7.90, ranking 66 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 18.42M, representing a year-over-year decrease of 2.66%, while its net profit experienced a year-over-year decrease of 228.16%.

Score

Industry at a Glance

Previous score

7.90

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

3.14

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.98

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.62

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

8.77

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Simulations Plus Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Simulations Plus Inc is 6.73, ranking 154 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -4.56, which is -2333.20% below the recent high of 101.80 and -95.57% above the recent low of -8.91.

Score

Industry at a Glance

Previous score

6.73

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 70/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Simulations Plus Inc is 7.43, ranking 132 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 22.50, with a high of 31.00 and a low of 16.00.

Score

Industry at a Glance

Previous score

7.43

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 7 analysts

Buy

Current Rating

24.750

Target Price

+75.04%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Simulations Plus Inc

SLP

Intuitive Surgical Inc

ISRG

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Simulations Plus Inc is 6.52, ranking 135 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 19.04 and the support level at 12.06, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.40

Change

0.12

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-1.285

Sell

RSI(14)

26.470

Sell

STOCH(KDJ)(9,3,3)

5.573

Oversold

ATR(14)

0.908

Low Volatility

CCI(14)

-114.140

Sell

Williams %R

92.264

Oversold

TRIX(12,20)

-0.638

Sell

StochRSI(14)

44.275

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

15.140

Sell

MA10

16.861

Sell

MA20

18.488

Sell

MA50

18.704

Sell

MA100

17.527

Sell

MA200

19.116

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Simulations Plus Inc is 7.00, ranking 80 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 78.38%, representing a quarter-over-quarter increase of 2.10%. The largest institutional shareholder is The Vanguard, holding a total of 1.01M shares, representing 5.02% of shares outstanding, with 7.80% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Woltosz (Walter S)

3.28M

-0.28%

BlackRock Institutional Trust Company, N.A.

1.06M

-52.66%

The Vanguard Group, Inc.

Star Investors

974.48K

-16.83%

Morgan Stanley & Co. LLC

832.51K

+233.61%

First Light Asset Management, LLC

767.76K

+114.96%

Rockefeller Capital Management

745.96K

+96.74%

Columbia Threadneedle Investments (UK)

602.47K

+0.15%

Tributary Capital Management, LLC

568.49K

+57.36%

Stephens Investment Management Group, LLC

392.84K

+46.27%

Dimensional Fund Advisors, L.P.

410.85K

-15.36%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Simulations Plus Inc is 5.91, ranking 71 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.16. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.